Antihypertensive drugs: clinical pharmacology and therapeutic use.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000031:analogs & derivatives; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D011224:Prazosin / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D046948:Secologanin Tryptamine Alkaloids; D013565:Sympatholytics; D000804:Angiotensin II; D009599:Nitroprusside; D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D003000:Clonidine; D003981:Diazoxide; D007741:Labetalol; D011188:Potassium; D011224:Prazosin